Literature DB >> 25578284

The cost of an Ebola case.

Sarah M Bartsch, Katrin Gorham, Bruce Y Lee.   

Abstract

As the most recent outbreak of Ebola virus disease (EVD) in West Africa continues to grow since its initial recognition as a Public Health Emergency of International Concern, an unanswered question is what is the cost of a case of Ebola? Understanding this cost will help decision makers better understand the impact of each case of EVD, benchmark this against that of other diseases, prioritize which cases may require response, and begin to estimate the cost of Ebola outbreaks. To date, the scientific literature has not characterized this cost per case. Therefore, we developed a mathematical model to estimate the cost of an EVD case from the provider and societal perspectives in the three most affected countries of Guinea, Liberia, and Sierra Leone. Our model estimates the total societal cost of an EVD case with full recovery ranges from $480 to $912, while that of an EVD case not surviving ranges from $5929 to $18 929, varying by age and country. Therefore, as of 10 December 2014, the estimated total societal costs of all reported EVD cases in these three countries range from $82 to potentially over $356 million.

Entities:  

Keywords:  Computational modeling,; Ebola; Economics,

Mesh:

Year:  2015        PMID: 25578284      PMCID: PMC4445295          DOI: 10.1179/2047773214Y.0000000169

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  26 in total

1.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

2.  Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

Authors:  Bruce Y Lee; Rachel R Bailey; Ann E Wiringa; Abena Afriyie; Angela R Wateska; Kenneth J Smith; Richard K Zimmerman
Journal:  Vaccine       Date:  2010-07-08       Impact factor: 3.641

3.  From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.

Authors:  Bruce Y Lee; Kristina M Bacon; Julie M Donohue; Ann E Wiringa; Rachel R Bailey; Richard K Zimmerman
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

4.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.

Authors:  Bruce Y Lee; Sarah M McGlone; Rachel R Bailey; Ann E Wiringa; Shanta M Zimmer; Kenneth J Smith; Richard K Zimmerman
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

Review 6.  Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.

Authors:  Daniel G Bausch; A G Sprecher; Benjamin Jeffs; Paul Boumandouki
Journal:  Antiviral Res       Date:  2008-02-26       Impact factor: 5.970

7.  The weight of nations: an estimation of adult human biomass.

Authors:  Sarah Catherine Walpole; David Prieto-Merino; Phil Edwards; John Cleland; Gretchen Stevens; Ian Roberts
Journal:  BMC Public Health       Date:  2012-06-18       Impact factor: 3.295

8.  Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania.

Authors:  Shawn T Brown; Julie H Y Tai; Rachel R Bailey; Philip C Cooley; William D Wheaton; Margaret A Potter; Ronald E Voorhees; Megan LeJeune; John J Grefenstette; Donald S Burke; Sarah M McGlone; Bruce Y Lee
Journal:  BMC Public Health       Date:  2011-05-20       Impact factor: 3.295

9.  The economic costs of malaria in children in three sub-Saharan countries: Ghana, Tanzania and Kenya.

Authors:  Elisa Sicuri; Ana Vieta; Leandro Lindner; Dagna Constenla; Christophe Sauboin
Journal:  Malar J       Date:  2013-09-03       Impact factor: 2.979

10.  Economic burden of cholera in the WHO African region.

Authors:  Joses M Kirigia; Luis G Sambo; Allarangar Yokouide; Edoh Soumbey-Alley; Lenity K Muthuri; Doris G Kirigia
Journal:  BMC Int Health Hum Rights       Date:  2009-04-30
View more
  12 in total

1.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

2.  Emerging infectious diseases: A proactive approach.

Authors:  David E Bloom; Steven Black; Rino Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

3.  Ebola Virus Disease Preparations Do Not Protect the United States Against Other Infectious Outbreaks.

Authors:  Shawn G Gibbs; John J Lowe; Aurora B Le; Jocelyn J Herstein; Paul D Biddinger
Journal:  Am J Public Health       Date:  2018-10       Impact factor: 9.308

4.  Rapid detection of Ebola virus with a reagent-free, point-of-care biosensor.

Authors:  Justin T Baca; Virginia Severns; Debbie Lovato; Darren W Branch; Richard S Larson
Journal:  Sensors (Basel)       Date:  2015-04-14       Impact factor: 3.576

5.  The Ebola Outbreak of 2014-2015: From Coordinated Multilateral Action to Effective Disease Containment, Vaccine Development, and Beyond.

Authors:  Thomas R Wojda; Pamela L Valenza; Kristine Cornejo; Thomas McGinley; Sagar C Galwankar; Dhanashree Kelkar; Richard P Sharpe; Thomas J Papadimos; Stanislaw P Stawicki
Journal:  J Glob Infect Dis       Date:  2015 Oct-Dec

6.  Assessing the feasibility of fly based surveillance of wildlife infectious diseases.

Authors:  Constanze Hoffmann; Melanie Stockhausen; Kevin Merkel; Sébastien Calvignac-Spencer; Fabian H Leendertz
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

7.  Global Health Solidarity.

Authors:  Peter G N West-Oram; Alena Buyx
Journal:  Public Health Ethics       Date:  2016-05-06       Impact factor: 1.940

8.  The monetary value of human lives lost through Ebola virus disease in the Democratic Republic of Congo in 2019.

Authors:  Joses M Kirigia; Rose Nabi Deborah Karimi Muthuri; Newton Gitonga Muthuri
Journal:  BMC Public Health       Date:  2019-09-03       Impact factor: 3.295

9.  An introduction to economic studies, health emergencies, and COVID-19.

Authors:  Lorcan Clarke
Journal:  J Evid Based Med       Date:  2020-05

10.  Costs and benefits of early response in the Ebola virus disease outbreak in Sierra Leone.

Authors:  Klas Kellerborg; Werner Brouwer; Pieter van Baal
Journal:  Cost Eff Resour Alloc       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.